J. Kellogg Parsons, MD, MHS, FACS, discusses the role of the National Comprehensive Cancer Network (NCCN) Prostate Cancer Early Detection guidelines in the PSA screening debate. He then provides commentary on the three algorithms included in the guidelines.
Read More
J. Kellogg Parsons, MD, MHS, FACS, reviews general principles of patient safety as applied to urologic practice. He provides practical instructions about handling urologic complications, specifically rhabdomyolysis, venous thromboembolism (VTE), air embolism, laparoscopic bowel injury, and prostate biopsy infections.
Read More
J. Kellogg Parsons, MD, MHS, FACS, reviews the 2018 American Urological Association (AUA) Guidelines for benign prostatic hyper-plasia (BPH). He emphasizes the topics excluded from the guidelines, as well as statements on preoperative evaluation, surgical therapies, and medically-complicated patients.
Read More
Seth R. Blacksburg, MD, MBA, explains the rationale for hypofractionation for prostate cancer and reviews the modality’s biochemical control, toxicity, and cost-effectiveness through prospective and randomized trials. He also discusses stereotactic body radiation therapy (SBRT) as an alternative treatment option.
Read MoreGrand Rounds in Urology published these consensus statements from the Future Directions in Urology Symposium (FDUS) 2018. These consensus statements represent a comprehensive analysis of current issues, challenges, and advancements in urology from a panel of international experts.
Read More